ZURA
ZURA Bio-A (ZURA)
NASDAQ
$3.95+$0.09 (+2.33%)
Price as of Jun 03, 2026 7:43 PM EDT
  • N/A
    Market Cap
  • 283.18%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-42.1M
+72.46%
-24.4M
-44.54%
-44.0M
N/A
N/A
N/A
Depreciation and Amortization Expense
49,000
+444.44%
9,000
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
75.2M
+36.34%
55.2M
-11.89%
62.6M
+2,630.47%
2.3M
+218.31%
Operating Profit
-75.2M
+36.34%
-55.2M
-11.89%
-62.6M
+2,241.48%
-2.7M
+201.07%
Interest Income
6.3M
-20.78%
8.0M
+265.87%
2.2M
+383,408.77%
570
+1,017.65%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
6.3M
-20.78%
8.0M
+265.87%
2.2M
+383,408.77%
570
+1,017.65%
Total Nonoperating Income and Expense
6.6M
+136.76%
2.8M
+34.27%
2.1M
-66.66%
6.2M
-19.55%
Income before Taxes
-68.7M
+31.00%
-52.4M
-13.47%
-60.6M
+2,163.92%
-2.7M
+201.07%
Income Taxes
N/A
N/A
0
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-68.7M
+31.00%
-52.4M
-13.18%
-60.4M
-1,800.70%
3.5M
-48.18%
Net Income from Continuing Operations Applicable to Common
-99.4M
+118.91%
-45.4M
-34.45%
-69.2M
-2,050.99%
3.5M
-48.18%
Basic EPS and Net Income
-1.06
+76.67%
-0.60
-71.29%
-2.09
-597.62%
0.42
-66.13%
Diluted EPS and Net Income
-1.06
+76.67%
-0.60
-71.29%
-2.09
-597.62%
0.42
-65.57%
Basic Weighted Average Shares
94.2M
+25.43%
75.1M
+127.05%
33.1M
+91.68%
17.3M
+57.32%
Diluted Weighted Average Shares
94.2M
+25.43%
75.1M
+127.05%
33.1M
+91.68%
17.3M
+54.78%
Balance Sheet
Cash and Cash Equivalents
109.4M
-38.01%
176.5M
+76.84%
99.8M
+723,918.86%
13,785
-98.11%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
109.4M
-38.01%
176.5M
+76.84%
99.8M
+723,918.86%
13,785
-98.11%
Total Current Assets
112.3M
-37.17%
178.7M
+77.25%
100.8M
+731,441.53%
13,785
-98.80%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
126,000
+38.46%
91,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
1.5M
+116.62%
698,000
N/A
0
-100.00%
142.1M
+1.94%
Total Assets
113.9M
-36.53%
179.5M
+78.03%
100.8M
-28.74%
141.5M
+0.68%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
7.8M
+2,081.13%
355,595
+12,281.44%
Total Current Liabilities
12.4M
-36.40%
19.5M
-3.88%
20.3M
+1,010.47%
1.8M
+571.42%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
6.6M
-34.91%
Total Liabilities
12.4M
-36.40%
19.5M
-8.35%
21.3M
+174.39%
7.8M
-25.04%
Retained Earnings
-224.5M
+44.04%
-155.9M
+50.63%
-103.5M
+1,257.02%
-7.6M
-16.93%
Total Stockholders Equity
101.5M
-30.84%
146.8M
+147.45%
59.3M
+877.97%
-7.6M
-16.93%
Total Shares Outstanding
73.7M
+12.84%
65.3M
+49.79%
43.6M
N/A
0
-100.00%
Cash Flow
Cash from Operating Activities
-64.8M
+130.86%
-28.1M
+86.50%
-15.1M
+1,305.56%
-1.1M
-2.47%
Capital Expenditures
113,000
+50.67%
75,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-113,000
-97.77%
-5.1M
-36.56%
-8.0M
-94.26%
-139.4M
0.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-2.2M
-101.97%
109.8M
-9.44%
121.3M
+34,009.87%
355,595
-99.75%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-46.78%
+25.15%
-37.38%
-24.96%
-49.81%
-2,079.34%
2.52%
N/A
Return on Equity
-55.28%
+8.74%
-50.84%
-78.23%
-233.48%
+452.84%
-42.23%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
9.05
-1.20%
9.16
+84.41%
4.97
+66,128.00%
0.008
N/A
Cash Ratio
8.82
-2.53%
9.04
+83.98%
4.92
+65,448.00%
0.008
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow